
Wells Fargo reiterated an Underweight on MGM with a $31 price target while the stock trades at $35.37 (market cap $9.05B); the firm cut several Q1 2026 segment EBITDAR estimates (Regionals to $267M from $296M; MGM China to $307M from $329M) and trimmed full-year Regionals to $1.045B from $1.123B, citing weather headwinds and acquisition-timing shifts (Northfield Park now expected to close June 1). Conversely Wells Fargo raised full-year 2026 Las Vegas EBITDA to $2.743B (+3% vs prior) and kept Digital estimates steady with an expected inflection in Q4 2026. MGM reported a strong Q4 2025 beat (EPS $1.23 vs $0.61 forecast; revenue $4.61B vs $4.42B) but analyst views remain mixed (Stifel PT $50 Buy; Goldman Sachs PT $34 Sell; Barclays PT $37 Equalweight).
MGM’s capital allocation and earnings mix (Strip, regionals, China, digital) creates a high gamma profile: upside if Las Vegas demand re-accelerates later in 2026, but meaningful downside if near-term regional weather and China volatility persist. The staggered timing of the regional acquisition shifts free cash flow and compresses near-term margin visibility, increasing the odds of multiple compression before any Strip-driven re-rating materializes. Second-order winners are smaller regional operators and pure-play domestic route operators with lower leverage; they avoid Macau hold noise and acquisition timing risk and could capture share if larger operators pause discretionary marketing or defer rollout of loyalty incentives. Conversely, vendors and contractors tied to Caesars/MGM capex cycles could see project deferrals ripple through 2-4 quarters. Key catalysts to watch with distinct horizons: weekly hold reports and March‑May weather patterns (days–weeks) that drive immediate revenue volatility; the formal close and integration milestones on regional deals (quarterly cadence) that influence covenant/FCF outlook; and Strip visitation/room rate recovery metrics into late‑2026 that determine whether multiples re-expand or compress further. The trade-off is classic optionality: patient capital wins if you manage tail risk around hold and deal-execution events.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
0.15
Ticker Sentiment